Pluslife hpv-16/18/45 nucleic acid test card

1. Pluslife hpv-16/18/45 nucleic acid test card is associated with assay performance agreement in humans (95.8% (95% CI: 87.7, 103.9)).

   “In 50 contrived clinical swabs, PPA was 100.0% (95% CI: 88.4, 100.0), NPA was 95.0% (95% CI: 75.1, 99.9), and overall agreement was 95.8%”

   Humansin 50 contrived clinical swabs

   HPV-Based Cervical Cancer Screening at the Point-of-Care? A Preclinical Evaluation of the Pluslife HPV 16/18/45 Assay · Preprints.org · 9 Sep 2026 · Preprint

Assay performance agreement →